These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6962827)

  • 1. Comparative distribution of Baker's antifolate (NSC 139105) in rat tissues after subcutaneous and intravenous injections.
    Yang BC; Ho DH; Brown NS; Benjamin RS; Bodey GP
    J Med; 1980; 11(5-6):413-24. PubMed ID: 6962827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of [14C] BBR 3053, an alkylating bisphosphonate, after single i.v. and multiple s.c. administration in rats.
    Bernareggi A; Crippa MT; Bastrup U; Di Giovine S; Cesarini R; Tognella S
    Boll Chim Farm; 1997 Apr; 136(4):304-7. PubMed ID: 9281891
    [No Abstract]   [Full Text] [Related]  

  • 3. Irreversible enzyme inhibitors. 197. Water-soluble reversible inhibitors of dihydrofolate reductase with potent antitumor activity derived from 4, 6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine.
    Baker BR; Ashton WT
    J Med Chem; 1973 Mar; 16(3):209-14. PubMed ID: 4733101
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement of antitumor activity of 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine and Baker's antifol (triazinate) with carboxypeptidase G1.
    Kalghatgi KK; Moroson BA; Horváth C; Bertino JR
    Cancer Res; 1979 Sep; 39(9):3441-5. PubMed ID: 476673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible enzyme inhibitors. 173. Cure of Walker 256 ascites by reversible and irreversible inhibitors of dihydrofolic reductase derived from 1-(substituted-phenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine.
    Baker BR; Vermeulen NM; Ashton WT; Ryan AJ
    J Med Chem; 1970 Nov; 13(6):1130-40. PubMed ID: 5479852
    [No Abstract]   [Full Text] [Related]  

  • 6. Multi-targeted antifolate (MTA): pharmacokinetics of intraperitoneal administration in a rat model.
    Pestieau SR; Stuart OA; Sugarbaker PH
    Eur J Surg Oncol; 2000 Nov; 26(7):696-700. PubMed ID: 11078617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative studies of clinically equivalent doses of various cytostatic agents on the mouse Ehrlich ascites carcinoma and rat Walker carcinosarcoma 256 in vivo and in cell culture (in vitro)].
    Matthias M; Tanneberger S; Gummel H
    Arch Geschwulstforsch; 1970; 36(3):240-6. PubMed ID: 5498278
    [No Abstract]   [Full Text] [Related]  

  • 8. Tissue distribution and depletion kinetics of bortezomib and bortezomib-related radioactivity in male rats after single and repeated intravenous injection of 14 C-bortezomib.
    Hemeryck A; Geerts R; Monbaliu J; Hassler S; Verhaeghe T; Diels L; Verluyten W; van Beijsterveldt L; Mamidi RN; Janssen C; De Coster R
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):777-87. PubMed ID: 17285316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of adjuvant hyaluronidase in tumors refractory to chemotherapy. Review of the literature and pharmacokinetics of cisplatin after regional administration in animals and humans].
    Civalleri D; Esposito M; De Cian F; Balletto N; Vannozzi MO; Mondini G; Carrabetta S; Bocchio MM
    G Chir; 1997 Apr; 18(4):175-81. PubMed ID: 9303630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioreductive metabolism of the novel benzotriazine di-N-oxide hypoxic cell cytotoxin tirapazamine (WIN 59075; SR 4233; NSC 130181) in mice.
    Walton MI; Workman P
    J Pharmacol Exp Ther; 1993 May; 265(2):938-47. PubMed ID: 8496834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and disposition of Baker's antifolate (NSC-139105), ftorafur (NSC-148958), and dichloroallyl lawsone (NSC-126771) in man.
    Loo TL; Benjamin RS; Lu K; Benvenuto JA; Hall SW; McKelvey EM
    Drug Metab Rev; 1978; 8(1):137-50. PubMed ID: 363378
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy of experimental meningeal carcinomatosis.
    Ushio Y; Posner JB; Shapiro WR
    Cancer Res; 1977 Apr; 37(4):1232-7. PubMed ID: 844048
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase I studies with Baker's Antifol (BAF) (NSC 139105).
    Rodriguez V; Gottlieb J; Burgess MA; Livingston R; Wheeler W; Spitzer G; Bodey GP; Blumenschein GR; Freireich EJ
    Cancer; 1976 Aug; 38(2):690-4. PubMed ID: 974989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of dibromodulcitol (NSC 104800) on intravenously induced cytemia of rats.
    Németh L
    Neoplasma; 1971; 18(5):533-7. PubMed ID: 5119525
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective uptake of the anticancer drug bendamustine by liver and kidney tissues following its intravenous administration to mice.
    Bezek S; Kukan M; Scasnár V; Lukácsová M; Trnovec T
    Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):117-22. PubMed ID: 8740243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
    Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
    Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the solid Walker-carcinosarcoma 256 in the rat during administration of cytostatics].
    Mattern J; Volm M; Wayss K
    Arzneimittelforschung; 1972 Oct; 22(10):1721-2. PubMed ID: 4677063
    [No Abstract]   [Full Text] [Related]  

  • 18. The antitumor activity of Cu(II)KTS, the copper (II) chelate of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone).
    Crim JA; Petering HG
    Cancer Res; 1967 Jul; 27(7):1278-85. PubMed ID: 4952520
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced therapeutic effect against liver W256 carcinosarcoma with temperature-sensitive liposomal adriamycin administered into the hepatic artery.
    Zou Y; Yamagishi M; Horikoshi I; Ueno M; Gu X; Perez-Soler R
    Cancer Res; 1993 Jul; 53(13):3046-51. PubMed ID: 8319211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of Walker carcinoma on the distribution of S35-lipoic acid in the body of white rats].
    Karpov LM; Rozanov AIa; Savvov VI
    Vopr Onkol; 1973; 19(12):57-61. PubMed ID: 4595158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.